01Research Directions

L-Lysine HCl research directions

01Research Directions

Why this compound has a literature

Lysine's research literature is shaped by one fact: it is the first limiting amino acid in wheat, rice and most other cereal staples. That gave it a public-health nutrition literature — fortification field trials in cereal-dependent populations — that is unusual for a supplement-grade amino acid, and a well-developed requirement-estimation and bioavailability literature using stable isotope methods. Alongside these sits a much older and much weaker clinical literature on herpes simplex prophylaxis, and a substantial animal-nutrition literature that accounts for most global lysine tonnage.

02Literature

What the literature investigates

Cereal fortification field trials

Because lysine is the first limiting amino acid for protein utilisation from wheat, several controlled fortification trials were run in populations obtaining most of their protein from cereal. A three-month double-blind study near Peshawar, Pakistan enrolled 80 families, in which wheat provided 58-65% of protein, and reported greater increases in children's weight and height in the lysine-fortified group, along with changes in haemoglobin, transferrin and prealbumin. A parallel three-month randomised double-blind study in poor communities in northwest Syria reported reduced plasma cortisol response to blood drawing in females, reduced sympathetic arousal by skin conductance in males, and reduced trait anxiety scores in males. These are population-specific studies conducted in settings of marginal lysine intake; the findings describe correction of an inadequate baseline intake and cannot be generalised to populations with adequate protein intake. A 2025 review of lysine for childhood and adolescent growth surveyed this literature and set out precautions.

Requirement estimation and food-matrix bioavailability

Lysine is one of the most thoroughly measured amino acids in the indicator amino acid oxidation (IAAO) literature. A 2024 study in 30 healthy adults over 60 reported requirement estimates stratified by age and sex, giving a mean of 32.9 mg/kg/day (upper 95% CI 40.9) for women aged 60-69 and 46.2 mg/kg/day (upper 95% CI 53.7) for women over 70, against a current recommendation of 30 mg/kg/day derived from young-adult data. Separate IAAO studies have measured lysine bioavailability from specific food matrices, reporting 94% bioavailability from moist-cooked sorghum in five healthy young men. This literature is methodologically strong but small in sample size, and it addresses dietary adequacy rather than supplemental intake. It is nonetheless the most defensible technical basis for discussing lysine dosing in fortification applications.

The herpes simplex prophylaxis literature and its limits

Lysine's best-known consumer association rests on a body of trials mostly published between 1978 and 1984, with conflicting results — some reporting subjective improvement, others reporting outright failure. A 2017 evidence review of oral L-lysine for herpes simplex recurrence concluded that supplementation appears ineffective for prophylaxis or treatment at doses below 1 g/day without a low-arginine diet, that doses above 3 g/day appeared to improve patients' subjective experience, and that longer controlled studies at doses exceeding 1.2 g/day are required to test the question definitively; the review also flagged theoretical cautions for patients with cardiovascular or gallbladder disease. The veterinary analogue was tested more rigorously and came out negative: a 2015 systematic review concluded that lysine supplementation was not effective for prevention or treatment of feline herpesvirus 1 infection in cats. Formulators should treat this area as unresolved and note that claim wording here is closely scrutinised in most markets.

Tolerance and the dose ceiling in the intervention literature

Lysine has an unusually well-organised safety literature for an amino acid. A 2020 systematic review pooled 71 intervention studies covering 3,357 subjects, doses up to 17.5 g/day and dosing periods up to 1,095 days, and reported that observed adverse events were mainly subjective gastrointestinal symptoms, with a risk ratio of 1.02 that was not statistically significant, and identified a provisional no-observed-adverse-effect level of 6.0 g/day. A general review of amino acid supplement side effects separately discussed competition among amino acids for shared membrane transporters and degradative enzymes, which is the mechanism most often raised when a single amino acid is dosed well above dietary levels. Together these define the range within which the published human literature actually operated.

03Specification

What this means when you specify the material

Two numbers anchor most lysine specification discussions. The intervention safety review pooled doses up to 17.5 g/day and identified a provisional NOAEL of 6.0 g/day, and the IAAO requirement work sits around 30-46 mg/kg/day depending on age and sex. Note that this SKU is the hydrochloride at roughly 82% lysine base, so any dose taken from the literature — which is almost always expressed as free lysine — must be converted before it is applied to a label or a fortification calculation. The fortification trials used lysine added to flour at dietary-adequacy levels, not supplement-scale doses.

04References

Cited literature

Research context only. Each entry describes what a published study examined and reported. These are not claims about this raw material, and not claims about any finished product. Regulatory and labelling judgements belong to the brand placing the product on its market.

In a three-month double-blind study of 80 families near Peshawar, Pakistan, where wheat supplied 58-65% of dietary protein, children in the lysine-fortified flour group showed significantly greater increases in weight and height than controls, with reported changes in haemoglobin, transferrin and prealbumin. Hussain T, Abbas S, Khan MA, Scrimshaw NS. Food Nutr Bull. 2004;25(2):114-22. PMID 15214256 DOI 10.1177/156482650402500202
In a three-month randomised double-blind study in economically weak wheat-staple communities in northwest Syria, lysine fortification was associated with a reduced plasma cortisol response to blood drawing in females, reduced skin-conductance sympathetic arousal in males, and reduced trait anxiety inventory scores in males. Smriga M, Ghosh S, Mouneimne Y, Pellett PL, Scrimshaw NS. Proc Natl Acad Sci U S A. 2004;101(22):8285-8. PMID 15159538 DOI 10.1073/pnas.0402550101
An indicator amino acid oxidation study in 14 healthy men and 16 healthy women over 60 reported mean lysine requirements of 32.9 mg/kg/day for women aged 60-69 and 46.2 mg/kg/day for women over 70, against a current recommendation of 30 mg/kg/day based on young-adult data. Rafii M, Paoletti A, He H, et al. J Nutr. 2024;154(7):2133-2142. PMID 38735574 DOI 10.1016/j.tjnut.2024.04.034
An indicator amino acid oxidation study in five healthy young men estimated the bioavailability of lysine from moist-cooked sorghum at 94% and assessed complementation with lentils in a mixed-meal format. Paoletti A, Fakiha A, Tul-Noor Z, et al. J Nutr. 2022;152(3):770-778. PMID 34871427 DOI 10.1093/jn/nxab410
An evidence review of oral L-lysine for herpes simplex recurrence concluded that supplementation appeared ineffective at doses below 1 g/day without a low-arginine diet, that doses above 3 g/day appeared to improve patients' subjective experience of the disease, and that longer controlled studies above 1.2 g/day are required to test the question definitively. Mailoo VJ, Rampes S. Integr Med (Encinitas). 2017;16(3):42-46. PMID 30881246
A systematic review concluded that lysine supplementation was not effective for the prevention or treatment of feline herpesvirus 1 infection in cats. Bol S, Bunnik EM. BMC Vet Res. 2015;11:284. PMID 26573523 DOI 10.1186/s12917-015-0594-3
A systematic review of 71 intervention studies (3,357 subjects, doses to 17.5 g/day, dosing periods to 1,095 days) reported that observed adverse events were mainly subjective gastrointestinal symptoms, with a non-significant risk ratio of 1.02, and identified a provisional no-observed-adverse-effect level of 6.0 g/day. Hayamizu K, Oshima I, Nakano M. J Nutr. 2020;150(Suppl 1):2561S-2569S. PMID 33000161 DOI 10.1093/jn/nxaa218
A review examined the evidence on lysine supplementation for growth in children and adolescents, noting its long use in populations whose staple diets are cereal-based, and set out precautions. Gunarathne R, Guan X, Feng T, Zhao Y, Lu J. J Adv Res. 2025;70:571-586. PMID 38740261 DOI 10.1016/j.jare.2024.05.014

Need this grade for your line?

RFQ